From Discovery Biology to ELRIG Chair: A Conversation with Melanie Leveridge

FHS
June 13, 2024
10:57 am

In this interview, we speak with Melanie Leveridge, Vice President of Discovery Biology at AstraZeneca and Chair of the Board for ELRIG UK, to discuss her extensive career in the pharmaceutical industry, her role in fostering scientific innovation, and her vision for ELRIG’s future.

Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA?

SAN ANTONIO — Postmenopausal women with genomically low-risk early hormone receptor (HR)-positive breast cancer had a low risk of recurrence with endocrine therapy alone after

December 9, 2023

Can a Common Lab Test Diagnose Long COVID?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

August 18, 2024

Next-generation sequencing and machine learning used to map genetic landscape of pancreatic cancer

A new research paper was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.